193 related articles for article (PubMed ID: 9255793)
1. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain.
Nord K; Gunneriusson E; Ringdahl J; Ståhl S; Uhlén M; Nygren PA
Nat Biotechnol; 1997 Aug; 15(8):772-7. PubMed ID: 9255793
[TBL] [Abstract][Full Text] [Related]
2. 3-2-1: Structural insights from stepwise shrinkage of a three-helix Fc-binding domain to a single helix.
Ultsch M; Braisted A; Maun HR; Eigenbrot C
Protein Eng Des Sel; 2017 Sep; 30(9):619-625. PubMed ID: 28475752
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition by an in vitro evolved affibody.
Högbom M; Eklund M; Nygren PA; Nordlund P
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3191-6. PubMed ID: 12604795
[TBL] [Abstract][Full Text] [Related]
4. Binding site on human immunoglobulin G for the affinity ligand HWRGWV.
Yang H; Gurgel PV; Williams DK; Bobay BG; Cavanagh J; Muddiman DC; Carbonell RG
J Mol Recognit; 2010; 23(3):271-82. PubMed ID: 20049844
[TBL] [Abstract][Full Text] [Related]
5. Heat-induced structural and chemical changes to a computationally designed miniprotein.
Dudley JA; Park S; Cho O; Wells NGM; MacDonald ME; Blejec KM; Fetene E; Zanderigo E; Houliston S; Liddle JC; Dashnaw CM; Sabo TM; Shaw BF; Balsbaugh JL; Rocklin GJ; Smith CA
Protein Sci; 2024 Jun; 33(6):e4991. PubMed ID: 38757381
[TBL] [Abstract][Full Text] [Related]
6. Generation of human TMEM16F-specific affibodies using purified TMEM16F.
Kim E; Bang J; Sung JH; Lee J; Shin DH; Kim S; Lee BC
Front Mol Biosci; 2023; 10():1319251. PubMed ID: 38274091
[No Abstract] [Full Text] [Related]
7. Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds.
Blanchard PL; Knick BJ; Whelan SA; Hackel BJ
ACS Synth Biol; 2023 Dec; 12(12):3608-3622. PubMed ID: 38010428
[TBL] [Abstract][Full Text] [Related]
8. Adaptable, turn-on maturation (ATOM) fluorescent biosensors for multiplexed detection in cells.
Sekhon H; Ha JH; Presti MF; Procopio SB; Jarvis AR; Mirsky PO; John AM; Loh SN
Nat Methods; 2023 Dec; 20(12):1920-1929. PubMed ID: 37945909
[TBL] [Abstract][Full Text] [Related]
9. Biological Applications of Synthetic Binders Isolated from a Conceptually New Adhiron Library.
D'Ercole C; De March M; Veggiani G; Oloketuyi S; Svigelj R; de Marco A
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892215
[TBL] [Abstract][Full Text] [Related]
10. Interface-Based Design of High-Affinity Affibody Ligands for the Purification of RBD from Spike Proteins.
Song S; Shi Q
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687186
[TBL] [Abstract][Full Text] [Related]
11. Selection of Affibody Affinity Proteins from Phagemid Libraries.
Giang KA; Nygren PÅ; Nilvebrant J
Methods Mol Biol; 2023; 2702():373-392. PubMed ID: 37679630
[TBL] [Abstract][Full Text] [Related]
12. Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody-Drug Conjugates.
Xu K; Han J; Yang L; Cao L; Li S; Hong Z
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446189
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy.
Gabriele F; Palerma M; Ippoliti R; Angelucci F; Pitari G; Ardini M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240041
[TBL] [Abstract][Full Text] [Related]
14. Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis.
Klint S; Feldwisch J; Gudmundsdotter L; Dillner Bergstedt K; Gunneriusson E; Höidén Guthenberg I; Wennborg A; Nyborg AC; Kamboj AP; Peloso PM; Bejker D; Frejd FY
MAbs; 2023; 15(1):2209920. PubMed ID: 37184136
[TBL] [Abstract][Full Text] [Related]
15. Expression and Characterization of Intein-Cyclized Trimer of
Nandy S; Maranholkar VM; Crum M; Wasden K; Patil U; Goyal A; Vu B; Kourentzi K; Mo W; Henrickson A; Demeler B; Sen M; Willson RC
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674796
[No Abstract] [Full Text] [Related]
16. Live-cell super-resolution imaging of actin using LifeAct-14 with a PAINT-based approach.
Bhaskar H; Kleinjan DJ; Oi C; Gidden Z; Rosser SJ; Horrocks MH; Regan L
Protein Sci; 2023 Feb; 32(2):e4558. PubMed ID: 36585831
[TBL] [Abstract][Full Text] [Related]
17. AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors.
Hokanson CA; Zacco E; Cappuccilli G; Odineca T; Crea R
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551940
[TBL] [Abstract][Full Text] [Related]
18. Development of therapeutic antibodies for the treatment of diseases.
Wang Z; Wang G; Lu H; Li H; Tang M; Tong A
Mol Biomed; 2022 Nov; 3(1):35. PubMed ID: 36418786
[TBL] [Abstract][Full Text] [Related]
19. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
Zhang Q; Zhu H; Cui Z; Li Y; Zhuo J; Ye J; Zhang Z; Lian Z; Du Q; Zhao KN; Zhang L; Jiang P
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009008
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.
Hu X; Li D; Fu Y; Zheng J; Feng Z; Cai J; Wang P
Front Oncol; 2022; 12():917439. PubMed ID: 35785201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
